PIPRA AG, a visionary MedTech start-up based in Zurich, is at the forefront of developing revolutionary products that harness the power of A.I. and high-grade patient data for the prevention, prediction, and diagnosis of delirium. Our flagship product, PIPRA (Pre-Interventional Preventive Risk Assessment), is an advanced pre-operative risk assessment tool that accurately evaluates a patient's risk of developing postoperative delirium (POD).
